https://charts.traderzeitung.de/phases/US1511902041 string(1430) "{"isin":"US1511902041","name":"Celularity Inc","stock_id_xnas":65845052,"stock_id_xnys":null,"generated_at":"2026-09-24 00:50:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.25,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":1.24,"close_at":"2026-09-21 22:03:00","complete":true,"perf_pct":-0.8}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.185,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":-4.4355},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":1.18,"close_at":"2026-09-22 23:04:00","complete":true,"perf_pct":-0.4219}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.169,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-0.9322},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Celularity Aktie News & Nachrichten

[WKN: A402TR | Symbol: CELU]

Realtimekurs

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Celularity gefunden werden.

Celularity Nachrichtenticker öffnen

MT Newswires 26.06.2026 11:50 Uhr

Celularity ernennt Chief Operating Officer

05:49 AM EDT, 06/26/2026 (MT Newswires) -- Celularity (CELU) hat Steven Gordon zum Chief Operating and Administrative Officer ernannt, teilte das Unte